Oct 26 (Reuters) - Endo International Plc ENDP.O
* Endo files federal lawsuit to obtain FDA compliance with drug quality and security act of 2013
* Endo International - lawsuit seeks immediate removal of vasopressin from FDA's Category 1 nominations list
* Endo - Units filed suit in court against FDA seeking declaration that FDA's current framework allowing bulk compounding of numerous products is unlawful
* Endo - seek removal of vasopressin from FDA's Category 1 nominations list to avoid bulk compounding of vasopressin by non-sterile-to-sterile outsourcing facilities